Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Receivables (2020 - 2025)

Privia Health has reported Receivables over the past 6 years, most recently at $400.9 million for Q4 2025.

  • Quarterly results put Receivables at $400.9 million for Q4 2025, up 26.8% from a year ago — trailing twelve months through Dec 2025 was $400.9 million (up 26.8% YoY), and the annual figure for FY2025 was $400.9 million, up 26.8%.
  • Receivables for Q4 2025 was $400.9 million at Privia Health, down from $499.0 million in the prior quarter.
  • Over the last five years, Receivables for PRVA hit a ceiling of $499.0 million in Q3 2025 and a floor of $98.4 million in Q3 2021.
  • Median Receivables over the past 5 years was $303.5 million (2023), compared with a mean of $283.6 million.
  • Biggest five-year swings in Receivables: surged 150.39% in 2022 and later rose 8.74% in 2024.
  • Privia Health's Receivables stood at $117.4 million in 2021, then surged by 61.5% to $189.6 million in 2022, then soared by 53.36% to $290.8 million in 2023, then increased by 8.74% to $316.2 million in 2024, then rose by 26.8% to $400.9 million in 2025.
  • The last three reported values for Receivables were $400.9 million (Q4 2025), $499.0 million (Q3 2025), and $444.0 million (Q2 2025) per Business Quant data.